Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Arrayit Corporation

Company price
0.0 USD 0.00(0%)
Last update at 2026-11-17T21:00:00Z
VOLUME
33000
Market Cap
0.11M

Momentum Score

…

Arrayit Corporation, a life sciences technology company, develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation, biological function, and diagnostics worldwide. The company is involved in the development and support of microarray tools and components; custom printing and analysis of microarrays for research; and the identification and development of diagnostic microarrays and tools for early detection of treatable disease states. It offers microarray printing technology, which allows the manufacture of DNA, protein, antibody, lipid, carbohydrate, and other types of microarrays for research and diagnostic applications, including gene expression, genotyping, protein profiling, and others. The company also provides automated microarray manufacturing instruments, including NanoPrint, SpotBot Titan, SpotBot Extreme, SpotBo Protein, and Personal microarrayers, as well as SpotLight CCD fluorescence scanners, SpotWare colorimetric scanners, InnoScan laser scanners, TrayMix hybridization stations, ArrayMix hybridization stations, centrifuges, air jets, vacuum products, and laboratory tools and bioinformatics computers. In addition, it manufactures consumables, such as glass substrates and slides, reagents, solutions, kits, and clean room supplies; and provides variation identification platform technology that allows diagnostic tests to be performed by depositing approximately 100,000 patient samples onto a single microarray. Further, the company is involved in the import, export, manufacture, and distribution of wholesale industrial chemicals. Arrayit Corporation offers its tools and services to genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government agencies, and biotechnology companies. The company is headquartered in Sunnyvale, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
0.00
Low
0.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Arrayit Corporation (OTC: ARYC.US) is a small-cap company with limited public disclosures that appears to operate in the life‑sciences/diagnostics area based on available materials. Long-term growth drivers could include commercial adoption of diagnostic technologies, strategic partnerships or licensing, and progress on product development or regulatory milestones, though detailed information is sparse. The stock may interest investors seeking exposure to early-stage diagnostics and the potential upside from clearer disclosures or commercial traction.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
2.82M
Revenue Per Share
0.01
Gross Profit TTM
1.39M
Debt / Equity
-
ROE
-
Net Debt
-
ROCE
22.99%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2014-12-31 2013-12-31 2012-12-31 2011-12-31
Type yearly yearly yearly yearly
Date 2014-12-31 2013-12-31 2012-12-31 2011-12-31
Income before tax -3.32M -0.38M -0.58M -0.25M
Minority interest - - - -0.04M
Net income -3.32M -0.38M 0.23M -0.20M
Selling general administrative 4.01M 1.84M 3.20M 1.40M
Gross profit 2.58M 1.12M 1.22M 1.50M
Ebit -1.49M -0.78M -2.05M 0.06M
Operating income -1.49M -0.78M -2.05M 0.06M
Interest expense 0.00M 0.00M 0.00M 0.00M
Non recurring 0.25M 0.08M 0.09M -
Income tax expense 0.00M 0.00M 0.00M 0.00M
Total revenue 4.38M 2.90M 2.49M 3.81M
Total operating expenses 5.87M 3.68M 4.54M 3.75M
Cost of revenue 1.80M 1.78M 1.27M 2.31M
Total other income expense net -1.82M 0.40M 1.47M -0.31M
Net income from continuing ops -3.32M -0.38M -0.58M -0.25M
Net income applicable to common shares -3.32M -0.38M 0.23M -0.20M
Breakdown 2014-12-31 2013-12-31 2012-12-31 2011-12-31
Type yearly yearly yearly yearly
Date 2014-12-31 2013-12-31 2012-12-31 2011-12-31
Total assets 1.00M 1.54M 0.57M 0.50M
Other current assets 0.04M 0.19M 0.00M -
Total liab 7.50M 7.14M 8.21M 8.50M
Total stockholder equity -6.50M -5.61M -7.64M -7.97M
Other current liab 0.48M 0.25M 0.49M 0.40M
Common stock 0.05M 0.04M 0.03M 0.03M
Retained earnings -28.01M -24.70M -24.32M -24.54M
Other assets 0.10M 0.12M 0.02M 0.02M
Cash 0.02M 0.29M 0.00M 0.00M
Total current liabilities 7.50M 7.14M 8.21M 8.50M
Short term debt 0.25M 0.25M 0.28M 0.37M
Short long term debt 0.25M 0.25M 0.28M 0.37M
Other stockholder equity -1.55M - - -
Property plant equipment 0.17M 0.08M - 0.02M
Total current assets 0.73M 1.34M 0.55M 0.46M
Net tangible assets -6.50M -5.61M -7.64M -7.97M
Net receivables 0.20M 0.40M 0.23M 0.28M
Inventory 0.46M 0.46M 0.32M 0.18M
Accounts payable 1.06M 1.03M 1.50M 1.18M
Breakdown 2014-12-31 2013-12-31 2012-12-31 2011-12-31
Type yearly yearly yearly yearly
Date 2014-12-31 2013-12-31 2012-12-31 2011-12-31
Investments - - -0.00M -
Change to liabilities 0.24M -0.00M 0.85M 0.13M
Total cashflows from investing activities -0.14M -0.06M -0.00M -0.00M
Net borrowings 0.56M -0.15M -0.03M -0.21M
Total cash from financing activities 0.62M 2.21M -0.03M -0.21M
Change to operating activities 0.23M -0.51M 0.00M 0.11M
Net income -3.32M -0.38M 0.23M -0.20M
Change in cash -0.27M 0.29M -0.00M -0.01M
Total cash from operating activities -0.75M -1.86M 0.03M 0.20M
Depreciation 0.04M 0.04M 0.02M 0.03M
Change to inventory -0.08M -0.14M -0.14M 0.12M
Change to account receivables -1.43M -0.16M 0.01M -0.09M
Sale purchase of stock 0.06M 2.36M 2.36M 2.36M
Change to netincome 3.50M -0.68M -0.94M 0.10M
Capital expenditures 0.14M 0.06M 0.06M 0.00M

Peer Comparison*

Sector: Healthcare Industry: Diagnostics & Research

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
TMO
Thermo Fisher Scientific Inc
5.51
0.80%
692.30 34.71 23.87 4.62 4.43 5.29 20.89
DHR
Danaher Corporation
0.17
0.07%
228.58 29.09 28.01 5.67 3.20 6.00 19.09
WUXIF
WuXi AppTec Co. Ltd
-
-%
25.06 22.29 17.95 1.53 5.98 8.39 14.30
WUXAY
WuXi AppTec Co. Ltd
-0.38
1.56%
23.97 23.28 18.73 1.51 6.24 8.39 14.30

Profile*

Arrayit Corporation

Arrayit Corporation, a life sciences technology company, develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation, biological function, and diagnostics worldwide. The company is involved in the development and support of microarray tools and components; custom printing and analysis of microarrays for research; and the identification and development of diagnostic microarrays and tools for early detection of treatable disease states. It offers microarray printing technology, which allows the manufacture of DNA, protein, antibody, lipid, carbohydrate, and other types of microarrays for research and diagnostic applications, including gene expression, genotyping, protein profiling, and others. The company also provides automated microarray manufacturing instruments, including NanoPrint, SpotBot Titan, SpotBot Extreme, SpotBo Protein, and Personal microarrayers, as well as SpotLight CCD fluorescence scanners, SpotWare colorimetric scanners, InnoScan laser scanners, TrayMix hybridization stations, ArrayMix hybridization stations, centrifuges, air jets, vacuum products, and laboratory tools and bioinformatics computers. In addition, it manufactures consumables, such as glass substrates and slides, reagents, solutions, kits, and clean room supplies; and provides variation identification platform technology that allows diagnostic tests to be performed by depositing approximately 100,000 patient samples onto a single microarray. Further, the company is involved in the import, export, manufacture, and distribution of wholesale industrial chemicals. Arrayit Corporation offers its tools and services to genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations, government agencies, and biotechnology companies. The company is headquartered in Sunnyvale, California.

927 Thompson Place, Sunnyvale, CA, United States, 94085

408-744-1331

7

Name Title Year Born
Ms. Rene A. Schena Chairman, CEO & CFO 1963
Dr. Mark Schena Ph.D. Pres, Chief Science Officer, Treasurer, Sec., Scientific Advisor & Director 1963
Mr. Todd J. Martinsky Founder, Exec. VP, Scientific Advisor & Director 1965
Mr. Paul K. Haje VP of Sales & Marketing 1956
Mr. William L. Sklar Financial Consultant 1948
Mr. Ronald Cole Consultant NA
Dr. Mark Schena Ph.D. President, Chief Science Officer, Treasurer, Secretary, Scientific Advisor & Director 1963
Mr. Todd J. Martinsky Founder, Executive VP, Scientific Advisor & Director 1965
Mr. Paul K. Haje Vice President of Sales & Marketing 1956

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…